Curative Surgery: Clinical Trials

3 trials of Curative Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Completed 1
Phase 31Recruiting 1

Follow Curative Surgery: new trials by email Literature Review of Curative Surgery trials Research Report on Curative Surgery

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer
PD-1 inhibitor, CTLA-4 inhibitor, ctDNA/MRD testing - Colon Cancer, Deficient Mismatch Repair
Phase 2RecruitingFudan University232026-09-142026-09-25
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence
Gemcitabine, Nab paclitaxel, Cisplatin - Biliary Tract Cancer, Cholangiocarcinoma
Phase 2 / Phase 3RecruitingGruppo Oncologico del Nord-Ovest3002023-11-072026-09-09
CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
Nivolumab, Surgery, Radiotherapy, Nivolumab, Surgery, Chemoradiotherapy - Squamous Cell Carcinoma of the Oral Cavity
Phase 2CompletedThe Clatterbridge Cancer Centre NHS Foundation Trust212019-05-102025-02-25

Conditions studied

Biliary Tract Neoplasms (1)  ·  Carcinoma, Squamous Cell (1)  ·  Cholangiocarcinoma (1)  ·  Colonic Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasm, Residual (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Fudan University (1)  ·  Gruppo Oncologico del Nord-Ovest (1)  ·  The Clatterbridge Cancer Centre NHS Foundation Trust (1)

Countries

China (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Joseph Sacco, MBChB (1)  ·  Monica Niger, MD (1)

Results publications

PMID 30914290, PMID 30998813, PMID 37368098, PMID 38589856

NIH funding

2017 (1)